ZP SPV 3 K/S: Financial statements 2025
CVR: 41038039
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ZP SPV 3 K/S (CVR 41038039) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,039,000 compared with DKK -34,739,000 the year before. Equity in the 2025 report amounted to DKK 429,000. The solvency ratio was 47.7%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -1,039,000
- Equity
- DKK 429,000
- Total Assets
- DKK 899,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | 0 | -1M | 429K | - |
| 2024 | 6.8M | 6.8M | -34.7M | 1.5M | - |
| 2023 | 7.4M | 7.4M | 1.1M | 36.2M | - |
| 2022 | 37.8M | 37.8M | -1.8M | 35.2M | - |
| 2021 | 1.6M USD | 1.6M USD | 50K USD | 5.6M USD | - |
Official annual report
How creditworthy is ZP SPV 3 K/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ZP SPV 3 K/S has published its annual report for 2024. Revenue came to DKK 6,783,000, and the net result was DKK -34,739,000.
About ZP SPV 3 K/S
ZP SPV 3 K/S is a Danish company of the type Kommanditselskab based in Søborg, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of ZP General Partner 3 ApS. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,039,000 compared with DKK -34,739,000 the year before. Equity in the 2025 report amounted to DKK 429,000.
